NASHVILLE, Tenn. / Apr 04, 2025 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:
What: HCA Healthcare, Inc. 1Q 2025 Earnings Call
When: Friday, April 25, 2025 at 9:00 AM Central (10:00 AM Eastern)
How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx
Contact:
Frank Morgan, 615-344-2688, Vice President, Investor Relations, This email address is being protected from spambots. You need JavaScript enabled to view it.
If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx.
| Last Trade: | US$429.54 |
| Daily Change: | 2.85 0.67 |
| Daily Volume: | 972,926 |
| Market Cap: | US$100.510B |
August 27, 2025 July 25, 2025 | |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
